Charlottesville, United States
Charlottesville, United States

Time filter

Source Type

Nosek B.A.,University of Virginia | Errington T.M.,Center for Open Science
eLife | Year: 2017

The first results from the Reproducibility Project: Cancer Biology suggest that there is scope for improving reproducibility in pre-clinical cancer research. © 2017, eLife Sciences Publications Ltd. All rights reserved.


Elizabeth Iorns, Ph.D., Founder and CEO of Science Exchange will present the Reproducibility Project: Cancer Biology PALO ALTO, CA--(Marketwired - May 23, 2017) - Science Exchange, the world's leading marketplace for outsourced research & development, today announced that Elizabeth Iorns, Ph.D., Founder and CEO of Science Exchange has been invited to present at Novartis Institutes for Biomedical Research (NIBR) Seminar. She will present on the Reproducibility Project: Cancer Biology, hosted by Jay Bradner, President of NIBR. The weekly series is an academic seminar series open to the public and externals. Invited speakers are primarily external scientists from academic institutions. Elizabeth Iorns will share her thoughts and recent discoveries on the Reproducibility Project: Cancer Biology on Wednesday, May 31, 2017 from 12:00 - 1:00 p.m. at the NIBR headquarters in Cambridge, Massachusetts. This session will explore the project and initial results, and attendees are invited to join the discussion on whether replication studies could be utilized more frequently as a mechanism to identify qualified targets for further in-house assessment. The Reproducibility Project: Cancer Biology is a collaboration between Science Exchange and the Center for Open Science (COS) to independently replicate key experiments from high-impact published cancer biology studies. The project was initiated in response to multiple reports published from the pharmaceutical industry indicating that more than 70% of published findings could not be reproduced. Science Exchange sourced and project managed the replication experiments for the project which is published in eLife: https://elifesciences.org/collections/reproducibility-project-cancer-biology. "I am honored to speak at NIBR and explore the disruptive topic of reproducibility in our industry," said Dr. Elizabeth Iorns. "Science Exchange and NIBR share a vision to promote the development of science, research and innovation as well as advocate how entrepreneurs can bring about change in this industry." For more information about the event and NIBR Weekly Seminar Series 2017, please visit https://www.eventbrite.com/e/reproducibility-project-cancer-biology-tickets-34259041716 About Science Exchange Science Exchange is the world's leading marketplace for outsourced research. Science Exchange provides an efficient procure-to-pay platform for ordering services from the world's largest network of scientific service providers. Through Science Exchange, clients gain access to 3000+ qualified service providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. This increases scientists access to innovation and significantly improves their productivity because they are freed up from the administrative tasks and delays associated with sourcing, establishing and managing supplier contracts. At an organizational level, the Science Exchange enterprise program enables organizations to consolidate the long tail of research outsourcing spend into a single strategic supplier relationship driving significant efficiency and cost savings. To date, Science Exchange has raised over $30 million from Maverick Capital Ventures, Union Square Ventures, Index Ventures, OATV, the YC Continuity Fund, and others. For more information visit www.scienceexchange.com.


Miguel E.,University of California at Berkeley | Camerer C.,California Institute of Technology | Casey K.,Stanford University | Cohen J.,Stanford University | And 16 more authors.
Science | Year: 2014

Social scientists should adopt higher transparency standards to improve the quality and credibility of research.


News Article | December 15, 2015
Site: www.sciencenews.org

Experimental results that don’t hold up to replication have caused consternation among scientists for years, especially in the life and social sciences (SN: 1/24/15, p. 20). In 2015 several research groups examining the issue reported on the magnitude of the irreproducibility problem. The news was not good. Results from only 35 of 97 psychology experiments published in three major journals in 2008 could be replicated, researchers reported in August (SN: 10/3/15, p. 8). The tumor-shrinking ability of the cancer drug sunitinib was overestimated by 45 percent on average, an analysis published in October showed (SN: 11/14/15, p. 17). And a report in June found that, in the United States alone, an estimated $28 billion is spent annually on life sciences research that can’t be reproduced (SN: 7/11/15, p. 5). Estimated annual U.S. spending on preclinical research that is irreproducible There are many possible reasons for the problem, including pressure to publish, data omission and contamination of cell cultures (SN Online: 7/2/15; SN: 2/7/15, p. 22). Faulty statistics are another major source of irreproducibility, and several prominent scientific journals have set guidelines for how statistical analyses should be conducted. Very large datasets, which have become common in genetics and other fields, present their own challenges: Different analytic methods can produce widely different results, and the sheer size of big data studies makes replication difficult. Perfect reproductions might never be possible in biology and psychology, where variability among and between people, lab animals and cells, as well as unknown variables, influences the results. But several groups, including the Science Exchange and the Center for Open Science, are leading efforts to replicate psychology and cancer studies to pinpoint major sources of irreproducibility. Although there is no consensus on how to solve the problem, suggestions include improving training for young scientists, describing methods more completely in published papers and making all data and reagents available for repeat experiments.


News Article | December 22, 2015
Site: www.sciencenews.org

A single scientific study often represents years of sweat, tears and sometimes even blood. But it never stands alone. In science, success and validation of a finding depends not on the original work and person doing the experiments, but on the ability of other people to find the same thing. What happens when they don’t? “I was really confident our results would replicate,” says Ian Handley, a social psychologist at Montana State University in Bozeman. Handley was an author on a study that showed that people could be primed by words such as “action” to move more to fulfill an active goal or to perform better on cognitive tests. Words such as “still” would make them move less, and be relatively lazy in their cognitive tasks..  One experiment from that study was repeated in the Reproducibility Project, an initiative dedicated to duplicating findings in psychology. Despite Handley’s confidence, the replicators didn’t find any significant effect. Handley was philosophical. “That’s the breaks,” he says. “I’d be uncomfortable if I did something wrong. But we did an experiment. That’s what we found. We reported it.” Handley doesn’t take the failed duplication of his work personally. But, he says, he did worry. “It was in the back of my mind: Will they think we’re frauds?” A new study suggests that for Handley and others in his situation, it’s not as bad as they fear: Scientists overestimate how negatively other scientists will view them. “The climate around replication as being a threat rather than a compliment has produced some unfortunate discussions that suggest a scientist’s reputation hinges on being right, rather than getting it right,” says Brian Nosek, a psychologist the University of Virginia in Charlottesville and executive director for the Center for Open Science, which runs the Reproducibility Project. But replication is not an insult. It’s central to the scientific process. “There are always going to be things that are wrong in our science. No one should be blamed for having things be wrong or demonized for trying to correct them,” says Adam Fetterman, a social psychologist at the University of Essex in Colchester, England.  “It should be about the research and not about researcher.” But he says with social media promoting near-instant reactions, failed replications quickly get personal. “People are mocking failed replications and they’re equating a failed replication with questionable research practices, incompetence or cheating,” he explains. Fetterman and his colleague Kai Sassenberg of the University Tübingen in Germany decided to find out if a failed duplication is really as bad for a scientist’s reputation as people fear. Via social media, they recruited 281 scientists who had published scientific studies. In a survey, participants were asked to imagine a scientific result — either one of their own or a colleague’s. Imagine that someone has tried to replicate the result and failed. The scientist tweaks the methods, tries again, and fails again. Given this cringe-inducing scenario, survey participants were asked to rate how much other researchers would trust their work afterward, if they might call other results into to question and if their future work might come under the microscope. When it was their own work, the scientists assumed the impact of a failed replication would be larger than if the work was someone else’s. While the study can’t predict the effect of a replication failure on a scientist’s reputation in the real world, the results do suggest that scientists overestimate the negative effect on their reputations. “It’s a lot like the spotlight effect,” Fetterman says. Just as when you think the world is watching when you slop coffee down your front, in reality, few notice, and those that do probably won’t judge you as hard as you are judging yourself. If a repeat study proves the original wrong, is it better to stand by your findings? Or admit that the original results were wrong after all? When confronted with these options, the survey participants ranked those who admitted they were wrong more positively than those who defended themselves, Fetterman and Sassenberg report December 9 in PLOS ONE. Better to eat some humble pie in the face of a failed replication. “Scientific reputations appear to be more grounded in the scientist’s process of investigation and discovery, not in whether they got it all right the first time,” says Nosek. “That’s a good thing, because we almost never get it right the first time!” A single duplication failure shouldn’t doom an idea to the scientific dustbin, says Carina Sonnleitner, a psychologist at the University of Vienna in Austria. Sonnleitner was part of the team that tried to replicate Handley’s work. She explains that the failure to replicate is not a sign that Handley’s results were bad, or even wrong. The statistics involved in every scientific study are always about probability, she says. So there is always a chance, however small, that the first study — or its replication — was just a fluke. Many replications, and analysis of all the replications together, need to be done before drawing a conclusion. The new study also noted that admitting you’re wrong in the face of a failed replication can make people view you more positively. But it’s not always right to jump straight to groveling, argues Richard Petty, a social psychologist at Ohio State University in Columbus. “When someone fails to replicate, it’s not [clear] who’s wrong,” he says. When it’s certain that you are wrong, admit it, he says. But context — and other replications — matter as well. Petty says that in the case of his own work, “15 other labs have shown the same thing. If one attempt failed to get it, I’d be crazy to jump and say I must be wrong.” Reputations are important, but of course, the real question is, can Fetterman and Sassenberg’s finding be replicated? “Maybe,” says Fetterman. “There’s another set of researchers doing similar research. From the people I’ve talked to, they seem to have similar findings.” But the proof, as in the rest of science, will be in the eventual replication.


News Article | December 2, 2015
Site: www.nature.com

Emissions stall Humanity’s greenhouse-gas output increased by just 0.5% in 2014, despite significant global economic growth, according to figures released on 25 November. Carbon emissions rose by 3–4% per year in the first decade of the twenty-first century, but that growth has slowed dramatically over the past 3 years, report the Netherlands Environmental Assessment Agency and the European Commission’s Joint Research Centre. The biggest factor is China, where slower economic growth and a shift towards cleaner energy sources and less energy-intensive manufacturing have reduced the energy intensity of the economy. See go.nature.com/kphlae for more. Deforestation rises The rate of legal deforestation in the Amazon rainforest has risen over the past year, Brazilian environment minister Izabella Teixeira announced on 26 November. Satellite images show that 5,831 square kilometres of forest were lost to activities such as livestock farming and agriculture in the year up to July 2015, a 16% increase on the previous year. The increases were largest in the states of Rondônia, Mato Grosso and Amazonas. Of these, Mato Grosso had the biggest area of forest loss, at 1,508 square kilometres. Efforts by the Brazilian federal government have generally been bringing down rates of deforestation, and the current rate is around one-fifth of that in 2004. Blue Origin gets to space and back Commercial spaceflight company Blue Origin — the brainchild of Jeff Bezos, head of online retail giant Amazon — completed a test of its reusable rocket on 23 November. The autonomous vehicle was successfully landed after it propelled a capsule to a height of more than 100 kilometres, which is classed as being in space. The flight comes just seven months after one of the company’s rockets was destroyed during a similar test. Blue Origin has not yet completed a crewed flight; the capsule is designed to carry up to six passengers into space. Anthrax vaccine An anthrax vaccine has become the first to be approved by the US Food and Drug Administration (FDA) under the ‘Animal Rule’, which allows approval on the basis of animal tests when studies in humans are not ethical or possible. The FDA announced on 23 November that the vaccine, called BioThrax, can be used after exposure to Bacillus anthracis, the bacterium that causes anthrax. BioThrax was initially approved in 1970 to prevent anthrax before exposure to the bacterium. The vaccine is made by Emergent BioDefense Operations Lansing in Michigan. Retraction data A searchable database should soon allow systematic identification of retracted publications. Posts and article identifiers from the blog Retraction Watch will be incorporated into a web application maintained by Center for Open Science in Charlottesville, Virginia, that already tracks research activities such as posting preprints or depositing data sets. The resource will initially have about 5,000 entries, and was announced by both organizations on 24 November. LHC heavy metal After spending five months colliding protons following a major upgrade this year, the Large Hadron Collider (LHC) near Geneva, Switzerland, began a one-month run of experiments with heavy ions on 25 November. All main detectors at the accelerator — including ALICE, which was designed for this purpose — are now studying the state of matter known as quark–gluon plasma, which can arise when two nuclei of lead-208 collide. In these collisions, the nuclei carry a record-breaking energy of more than 1 petaelectronvolt. Energy partnership A group of 28 investors from 10 countries has launched a multibillion-dollar clean-energy research partnership. The Breakthrough Energy Coalition, spearheaded by Microsoft founder Bill Gates, and including Virgin founder Richard Branson and Amazon boss Jeff Bezos, was announced on 30 November, on the opening day of the international climate-change negotiations in Paris. The private partnership aims to support early-stage research into low-carbon technologies for future energy supply. It will complement energy-research efforts announced by US President Barack Obama and French President François Hollande on the same day, dubbed ‘Mission Innovation’. See go.nature.com/wzigmx for more. Maurice Strong Maurice Strong, the founding head of the United Nations Environment Programme (UNEP) and a leading figure in climate-change politics, has died aged 86. He was a major figure in organizing the 1992 Rio Earth Summit and creating the UN Framework Convention on Climate Change. Strong is regarded as one of the most important people in the history of the environmental and sustainability movements. In a statement released by UNEP on 28 November, Achim Steiner, the current head of the agency, called him a visionary and a pioneer of global sustainable development. Rhino-horn ban A South African court has lifted a ban on the domestic trade in rhino horn (pictured) after two game farmers claimed that it infringed their right to trade in a renewable substance. On 26 November, the judge ruled that the ban, introduced in 2009, had not undergone proper public consultation. He added that since 2008 the number of South African rhinos poached for their horns has increased from less than 100 per year to around 1,200. Conservation group Save the Rhino asked how a national ban could fuel poaching, which mainly serves overseas markets, given that the international trade is illegal. The South African government is to appeal the ruling; the law will stay in place until the appeal has been heard. Carbon plan canned On 25 November, the UK government scrapped a £1-billion (US$1.5-billion) competition to build a demonstration carbon capture and storage plant. Funding for the project — intended to demonstrate that carbon dioxide can be filtered out of power-plant exhaust gases on a commercial scale — has been on the table since 2012, but was removed from government plans in the latest five-year spending review. Open-access policy The Netherlands Organisation for Scientific Research (NWO) is tightening its open-access policy to demand that research results become universally available as soon as authors publish them. NWO-funded researchers were previously obliged either to publish in an open-access journal or to submit a version of their work to a public database ‘as soon as possible’ after publishing in a pay-to-read journal. From 1 December, new grant conditions require Dutch researchers to make work immediately accessible. To avoid conflicting with journals that enforce embargo periods, such as Nature, researchers can submit pre-peer-review versions to a database. Animal clones A huge animal-cloning centre in Tianjin, China, will open early in 2016. Launched with 200 million yuan (US$31.3 million) from Sinica, a subsidiary of BoyaLife in Wuxi, the Tianjin International Joint Academy of Biomedicine, Peking University in Beijing and Sooam Biotech in Seoul, the centre will clone cattle, dogs and racehorses. BoyaLife says that the aim is to produce one million cloned cow embryos annually to help Chinese farmers to meet demand for beef. Italian expo The Italian government enacted a decree on 25 November that allocates €80 million (US$85 million) to launch a major research centre to focus on big-data exploitation in health and nutrition, as well as nanotechnologies. Called Human Technopole, the centre will take over part of the site used for the 2015 international exhibition called Milan Expo. It will continue the theme of the exhibition — ‘feeding the planet, energy for life’. Human Technopole will be led by the Genoa-based Italian Institute of Technology and will eventually employ more than 1,000 researchers. European politicians often allow more fish to be taken from the seas than is recommended by scientists. Yet this excess varies by country, according to a study (G. Carpenter et al. Mar. Policy 64, 9–15; 2016). In 2001, the total catch permitted in the European Union averaged 33% more than that advised by the International Council for the Exploration of the Sea. In 2015, this fell to 7% above the advised level. EU politicians negotiate catch limits in secret, but more transparency is needed, say the authors. 3–4 December The first International Workshop on Metamaterials-by-design takes place in Paris. go.nature.com/hkzg9s 8–9 December The Royal Society of Medicine and the Nutrition Society in London jointly host a meeting that will look at the role of sleep in obesity and nutrition. go.nature.com/xigwne


News Article | December 23, 2015
Site: www.nature.com

Christiana Figueres: Climate guardian | Junjiu Huang: Embryo editor | Alan Stern: Pluto hunter | Zhenan Bao: Master of materials | Ali Akbar Salehi: Nuclear diplomat | Joan Schmelz: A voice for women | David Reich: Genome archaeologist | Mikhail Eremets: Super conductor | Christina Smolke: Fermenting revolution | Brian Nosek: Bias blaster | Ones to watch A dynamic leader charted the path to a new global climate agreement. By Jeff Tollefson Hours after the world’s governments adopted a landmark climate accord this month, Christiana Figueres was all smiles on the dance floor of a boisterous night club in Paris. As the leader of the United Nations climate convention, she had spent five long years travelling the world to rally support among environmentalists, businesses and govern­ments for the accord, in which 195 countries pledged to keep global warming to well below 2 °C. But now here she was, leading conga lines and dancing to the Village People’s classic ‘Y.M.C.A.’. Asked whether she ever had any doubts, she flashed a smile, pulled her hands together as if in prayer and pointed skyward. “The stars are guiding us,” she said. Born into a politically powerful family in Costa Rica, Figueres came by her activism naturally. Her father led the republic’s 1948 revolution and served as its first president. Her brother followed suit, with a term as president in the 1990s, and her mother served in the congress. Friends and colleagues credit Figueres for breaking out of her comfort zone in Costa Rica and jumping into the international environmental arena. “In this country, being a Figueres means something,” says Monica Araya, a former climate negotiator who founded Nivela, an environmental think tank based in Heredia, Costa Rica. “She built a whole career outside Costa Rica, and in a very important way she chose climate change as her activity.” Figueres attributes her environmental activism to the demise of a toad that disappeared from Costa Rica’s Monteverde Cloud Forest Reserve. She saw one when she was young, but her daughters missed the chance. “That was a real awakening for me,” she says, because rising temperatures have been linked to the toad’s extinction. “I started reading into the topic, and before I knew it I was devoting my life to climate change.” In 1995, after stints in the Costa Rican government at home and abroad, Figueres created a non-profit organization in Washington DC to encourage Latin American engagement in the newly minted UN climate convention. In parallel, she represented Costa Rica as a non-governmental climate negotiator — a move, Araya says, that helped to pave the way for other members of civil society to join the Costa Rican delegation. Over time, she became increasingly active in the governing secretariat of the UN convention and built up a reputation for getting things done. When Figueres was interviewed for her current post in 2010, she was asked what she would do if she were overruled by her boss. She offered up a quick joke: “Well, to begin with, I would fire him.” “She is brilliant, way above average, and she has a very well-developed sense of humour,” says Marco Gonzalez, a friend and fellow Costa Rican who formerly headed the UN treaty organization that was built to phase out chemicals that damage the stratospheric ozone layer. “She brings success in her backpack.” Figueres took charge of an organization and a process that she describes as “in the garbage can” after the diplomatic meltdown at the Copenhagen climate conference in 2009. The secretariat had previously concerned itself mostly with national governments, but Figueres expanded its sphere by reaching out to local and regional governments as well as the business sector. “Her fingerprint is all over the intense presence of cities and businesses in Paris,” says David Waskow, director of the International Climate Initiative at the World Resources Institute in Washington DC. Figueres used all of her political skills to help herd governments towards the Paris agreement — and her roots in a developing country helped her to bridge the gulf between rich and poor nations, a division that had plagued past negotiations. Although current climate pledges fall short of the accord’s ultimate goal, all nations have now committed to the battle against global warming. Throughout the process, Figueres says she has been driven by the same sense of duty that spurred her father: the desire to protect and expand opportunities for those who are less fortunate. “I happened to choose a different battleground at the global level, but it’s the same thing,” she says. “We have a huge moral responsibility to do everything that we can to improve that situation.” A modest biologist sparked global debate with an experiment to edit the genes of human embryos. By David Cyranoski In April, Junjiu Huang published the world’s first report of human embryos altered by gene editing. The news thrust rapid developments in gene-editing technology into the spotlight and ignited a huge debate about the ethical use of such tools. But Huang, a modest and soft-spoken molecular biologist at Sun Yat-sen University in Guangzhou, chose to stay out of the limelight. Huang and his team used a powerful technique known as CRISPR–Cas9, which can be programmed to precisely alter DNA at specific sequences and has swept through biology labs in the past few years. He told Nature in April that he wanted to edit the genes of embryos because: “It can show genetic problems related to cancer or diabetes, and can be used to study gene function in embryonic development.” In his study, he modified the gene responsible for the blood disorder β-thalassaemia. Huang used spare embryos — from fertility clinics — that could not progress to a live birth. And he expected his paper, which showed that the process created many unexpected mutations, to steer people away from the technology until it had been proved safe. “We wanted to show our data to the world so people know what really happened with this model,” he said at the time. “We wanted to avoid ethical debate.” But the opposite happened: the ensuing discussion polarized the scientific community and nucleated several high-powered forums, including an international summit held in December in Washington DC. The general consensus is that gene editing is not yet ready for altering human embryos for reproductive purposes — and there are concerns that it could be adopted prematurely by rogue fertility clinics. Some scientists argue that the technique is permissible for research, whereas others say that this too should be forbidden for fear of a slippery slope. Huang has been notably absent from the debate, and refused to be interviewed for this article. “Our paper was just basic research, which told people the risk of gene editing,” he wrote in an e-mail. “It’s like he’s hiding,” says Tetsuya Ishii, a bioethicist at Hokkaido University in Sapporo, Japan, who was at the US summit. “That’s strange because there was nothing really ethically problematic about his research. He raised the issue, and that kind of drove discussions on the topic at the summit. That’s a good thing.” But Ishii says that Huang does “have some responsibility to address his critics”, perhaps by discussing cases in which clinical use of gene editing could be worthwhile in the future. Because of the risks, Huang predicted when his paper was published that it could take 50 or 100 years before the world saw a live-born, gene-edited baby. “But who knows, a decade ago, no one knew of CRISPR,” he said. “We don’t know what will happen.” A single-minded planetary scientist brought the dwarf planet into focus. By Alexandra Witze Alan Stern, planetary scientist and workaholic, doesn’t sleep much at the best of times. In the days approaching 14 July — as the spacecraft he had dreamed about, worked for and slaved over for a quarter of a century neared its target — he was down to roughly three hours a night. Stern, of the Southwest Research Institute in Boulder, Colorado, is the principal investigator for NASA’s New Horizons mission, which in July became the first probe to visit Pluto. It whizzed just 12,504 kilometres above the dwarf planet’s surface, in an extraordinarily choreographed fly-by that grabbed images, spectra and other scientific data — as well as headlines around the world. Stern had been preparing for the day since 1989, when he and other young researchers hatched plans to visit the distant world. They submitted their proposal to NASA, and kept their hopes alive even when the agency killed plans for a Pluto mission in 2000 over budget concerns. After Congress revived funding for the concept, and NASA restarted the competition for proposals, Stern’s team won with a lean design that would carry a few key instruments. “That meant a laser focus on getting it there,” he says. Stern is nothing if not laser focused. Under his leadership, New Horizons blasted off in January 2006 at a cost of US$720 million, much less than earlier multibillion-dollar missions to the outer Solar System. His three children went through high school and into university with 14 July 2015 imprinted on their brains. When the day arrived, Stern and the rest of Earth got to see Pluto up close for the first time. Among his favourite discoveries: ice mountains that tower as high as 4 kilometres, dune fields that may ripple across Pluto’s surface, and skies that are tinted blue by atmospheric haze. A heart-shaped feature that showed up on images was a “public-relations bonanza”, he says, inspiring people around the world to connect with the dwarf planet. Stern’s drive to explore new worlds is also reflected in his focus on public relations, says David Grinspoon, a researcher with the Planetary Science Institute in Tucson, Arizona, who is working with Stern on a book about the mission. Stern convened an eclectic group of artists, writers and visionaries in New York City months before the fly-by to pick their brains about ways to connect with the general public. “It wasn’t your normal outreach team,” Grinspoon says. Stern pursues public engagement with a singular passion. He is known for seeking out — and scrutinizing — media coverage. Even during the most intense stages of the mission, Stern was tweeting prolifically and posting to Facebook while overseeing press releases. After the fly-by, Stern found himself swamped with speaking invitations. At an astronomy conference in Vermont, he talked for an hour, took questions for an hour and then met Pluto fans individually. Two university students told him that New Horizons was the best thing that had happened in their lifetime. Months after the Pluto visit, some members of the team experienced a post-fly-by depression. Not Stern. He drives ahead as always, working on the data that will dribble back from the spacecraft until late 2016. He is also resuming work on the European Space Agency cometary mission Rosetta, on which he has an ultraviolet spectro­meter instrument, and on plans to fly research payloads on suborbital spacecraft. He has a little more time for sleep these days, but not much. And in October and November, New Horizons ignited its engines to set it on course to visit a second Kuiper belt object, this one on New Year’s Day in 2019. If NASA approves the extended mission, Stern says, “I’m looking forward to finishing what we started”. A chemical engineer is merging electronics with the human body. By Erika Check Hayden Zhenan Bao rummages through a plastic box on her desk, eagerly pulling out samples of materials developed in her lab. She finds a thin, nearly weightless patch made of carbon nanotubes that attaches to the wrist like a sticking plaster and monitors the wearer’s heart rate. Then she picks up an artificial skin that uses tiny carbon-nanotube sensors to detect touch; and a version of it that even features hair-like structures to more closely mimic real skin. Bao, a chemical engineer at Stanford University in California and a founder of the field of thin, flexible organic electronics, shines a laser pointer through a sample of the nanotube material used in many of these devices. She laughs as the beam is diffracted into a spray of green dots on the wall, just as it would be when passing through a crystalline material. “That’s how we know it has regular structure,” she says. Innovations in her field are often inspired by nature, she says: “If we can understand how to design materials with the same degree of complexity, we will be able to address real-world problems.” A prime example is the creation of medical devices that can be worn or implanted to monitor blood sugar, send sensory signals and more. Progress towards that goal has taken off this year, with Bao’s lab among the leaders. In October, her team showed that its artificial skin could mimic the sense of touch (B. C.-L. Tee et al. Science 350, 313–316; 2015). The researchers took inspiration from human skin, in which specialized nerves fire more rapidly as pressure increases, producing a code that the brain interprets as touch. Previous artificial touch sensors required power-hungry external devices to generate that code. But in Bao’s sensors, pressure alters the oscillating frequency of microscopic circuits made from carbon nanotubes to generate the right kind of signals automatically. Although Bao calls the final design “simple”, it was a major accomplishment, says Polina Anikeeva, a neural-interfaces and materials scientist at the Massachusetts Institute of Technology in Cambridge. She notes that Bao has been working on perfecting these materials for years, and that her lab — which comprises around 40 chemists, chemical engineers and materials scientists — is highly interdisciplinary. “It’s not just one idea,” she says, “many ideas came together and made this possible.” “We have many years of work to do,” says Bao, who hopes that the treasures she keeps in the plastic box will one day help to revolutionize health care. “But generally, the path is laid out.” The head of Iran’s nuclear programme helped to forge a pact to keep it peaceful. By Davide Castelvecchi On 14 July 2015, Iran signed an agreement with six world powers to limit the country’s nuclear development in exchange for lifted international-trade sanctions. If the deal is implemented successfully — still far from certain — it could ease years of tension over Iran’s alleged efforts to build nuclear weapons and so allow the country to become a major player in global science. That an accord was reached at all, however, was due in no small measure to nuclear engineer Ali Akbar Salehi, who is head of the Atomic Energy Organization of Iran. He worked closely with his US counterpart, energy secretary Ernest Moniz, to iron out the deal’s technical aspects. Educated at the American University of Beirut and the Massachusetts Institute of Technology in Cambridge, Salehi returned to Iran after the Islamic revolution of 1979 and quickly rose to top posts in both academia and the government. By the 2000s, he had become the international face of Iran’s nuclear programme — a man described as fiercely loyal to his country, but also a voice of reason to whom negotiators could appeal in times of crisis. Salehi is said to be a deeply spiritual person who has the trust — and the ear — of the country’s supreme leader, Ayatollah Ali Khamenei. And he is one of very few people to have held senior posts in both hardline and comparatively liberal governments. This talent for building bridges is what enabled Salehi to work so effectively with Moniz during the negotiations, says Reza Mansouri, an astronomer at the Institute for Research in Fundamental Sciences in Tehran and a former deputy science minister of Iran; they shared the language of science. Mansouri, who has known Salehi for more than three decades, says that he has the modern, rational frame of mind that enables people to “agree on how to talk to each other”. They came forward, one by one. Young female astronomers sought out Joan Schmelz and confided in her about the sexual harassment that they had endured. Schmelz, a solar physicist and chair of the American Astronomical Society’s Committee on the Status of Women in Astronomy from 2009 to 2015, heard too many of these stories — and a lot of them involved the same man. Schmelz told the women that they were not alone, and asked whether they wanted to talk to others who were in the same situation. Thanks in part to those introductions, four women eventually filed complaints. Their actions, which became public this year, led to the resignation of Geoff Marcy, a well-known exoplanet hunter at the University of California, Berkeley. It was one of the most dramatic episodes in a string of gender-equality controversies this year, including Nobel laureate Tim Hunt’s dismissive comments about women working in the laboratory. In astronomy, Schmelz’s behind-the-scenes efforts to expose sexual harassment set the stage for a sea change in community understanding, says Meg Urry, an astronomer at Yale University in New Haven, Connecticut, and president of the astronomical society. After Marcy was outed, astronomy departments at universities and other institutions began frank discussions about unacceptable behaviour. “Without Joan, I don’t think we would have seen this remarkable change,” says Urry. Women were comfortable sharing their stories with Schmelz because she had been through the same thing. Early in her career, Schmelz had found herself the target of harassment by her supervisor. “I was very isolated, and I didn’t have anyone to confide in,” she says. She only began to realize what had happened to her years later, in 1991, when attorney Anita Hill accused Clarence Thomas, a judge nominated for the US Supreme Court, of sexual harassment. In 2011, Schmelz went public, through a blog post on the website of the Committee on the Status of Women in Astronomy. Then the Marcy stories started pouring in. “For a while I kept trying out how we could move forward — I contacted a lot of people, players in the community, to see if there was anything we could do for these women,” she says. Eventually the option emerged of filing complaints under the legislation known as Title IX, which prohibits sexual discrimination on campuses that receive federal funding. In July 2014, the first complaints hit Berkeley. “I wasn’t sure it would ever happen,” says Schmelz. All this intense work took place as Schmelz led a busy career in solar astronomy. In June this year, she took a job as deputy director of Arecibo Observatory in Puerto Rico. Months later, the director resigned, leaving Schmelz in charge of the world’s largest single-dish radio telescope. She now lives just a block from the beach, which offers a much-needed respite when she can spare the time. But Schmelz knows that her work on harassment is not over. She would like to press universities to keep long-term records of complaints. In most institutions, there is no method for tracking whether there have been one, two or ten incidents reported against a given person over time. “Let’s find ways to take the pressure off the young women, so they can work on their science, write a thesis, without all of this extra added burden on them,” says Schmelz. “Let’s change the system.” A big thinker helped to turn ancient genomics from niche pursuit to industrial process. By Ewen Callaway For most of its 30-year history, the field of ancient genetics has revolved around discovering exceedingly rare samples — a bone, a tooth — that harbour enough intact DNA to study. This year, population geneticist David Reich proved that it’s possible to explore human history by powering through ancient genomes en masse. Reich’s genome factory has revealed mass migrations, the spread of farming and the roots of languages. Last month, his group at Harvard Medical School in Boston, Massachusetts, reported genome data from 230 people who lived in Europe and the Middle East over the past 8,000 years, tracking changes in skin colour, immunity and other traits (I. Mathieson et al. Nature http://doi.org/9rb; 2015). At university, “I think I was sort of idealistic”, Reich says. “I was interested in grand unifying theories.” For his first degree, he switched from sociology to physics. During his second, in biochemistry, he fell for human population genetics, and soon built a reputation for scientific rigour. In the late 2000s, plummeting sequencing costs and other advances made it easier to extract and analyse ancient DNA. Reich realized that by analysing the genomes of large numbers of people, he could see how immigration and interbreeding changed the genetics of entire regions. In 2013, Reich opened his own lab devoted to sequencing ancient remains. Its scale was industrial from day one: the first human samples came from 66 individuals who had lived in what is now Russia, including members of a Bronze Age culture called the Yamnaya. In June, the team described a massive migration of Yamnaya people into Western Europe, some 5,000 years ago (W. Haak et al. Nature 522, 207–211; 2015). It is not the only group powering through ancient genomes: the lab of Eske Willerslev at the Natural History Museum of Denmark in Copenhagen reached a similar conclusion (M. E. Allentoft et al. Nature 522, 167–172; 2015). Reich’s team argued that the Yamnaya migration might also explain the radiation of Indo-European languages across Europe and Asia — advancing a problem that has vexed linguists for decades. By exploring the consequences of genetics for other fields, Reich “is trying to do something that a lot of geneticists might not”, says David Anthony, an archaeologist at Hartwick College in Oneonta, New York. Reich is eager to see genetics inform other debates, such as those about the peopling of the Americas and the prehistory of India. “The invention of ancient DNA as a tool for studying the past is like the invention of a new scientific instrument, like a microscope,” he says. “You can see into things that you couldn’t see before.” Decades of diligence earned one physicist a record for resistance-free electricity. By Edwin Cartlidge As a young researcher during the 1970s and 1980s, Mikhail Eremets proved to have a temperament well suited to life at the Institute for High Pressure Physics outside Moscow. The facilities were often abysmal, but the soft-spoken Belarusian was prepared to work around them — even dialling the same telephone number 100 times just to get a working line. “If I want to do something I am happy to repeat it many, many times,” says Eremets, who is now at the Max Planck Institute for Chemistry in Mainz, Germany. That doggedness has served him well in his quest to understand how materials behave at pressures close to those of Earth’s core — conditions that he recreates by squeezing tiny samples between the tips of two diamond ‘anvils’. These experiments have been painstaking and repetitive, with results that never troubled the Nobel committee. Until late 2014, that is, when Eremets and his colleagues reported hints that pressurized hydrogen sulfide — the compound responsible for the smell of rotting eggs — can become a superconductor, allowing electricity to flow without resistance at a record-breaking 190 kelvin (−83 °C) (A. P. Drozdov et al. Preprint at http://arxiv.org/abs/1412.0460; 2014). He and others published conclusive evidence — and measured an even higher temperature — in August (A. P. Drozdov et al. Nature 525, 73–76; 2015). The advance has been hailed as a giant step towards the long-sought goal of room-temperature superconductivity and the promise of loss-free electrical transmission. It has certainly rocked the physics community, says Igor Mazin of the Naval Research Laboratory in Washington DC. Other materials have produced superconductivity at high temperatures, but the mechanism by which hydrogen sulfide operates has never achieved superconductivity above 40 kelvin. No independent group has confirmed the result entirely, but Eremets is already planning experiments to see whether hydrides doped with chemicals can superconduct at normal, atmospheric pressure — an essential step towards practical use. Having done most of his important work since turning 50, he feels he has plenty of research left in him. “In that sense I am still a young, growing scientist,” he says. A synthetic biologist won a breakneck race to produce opioids in yeast. By Erika Check Hayden Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of making opioids. These powerful pain-killing drugs are crucial in medicine, but they come solely from opium poppy crops that can have unpredictable yields. Scientists were seeking a more stable production method but faced a daunting hurdle: no one had been able to identify an enzyme that converts reticuline — a chemical building block of morphine and other narcotics — from one form to another. Most other labs hunting for the enzyme were working to isolate it from poppies directly. But Smolke and her team at Stanford University, California, took a different approach: they combed through genetic databases, looking for snippets of sequence that looked as if they might be involved in reticuline metabolism. When they found a hit from several different poppy species, they ordered a synthetic version of the gene that had been built letter-by-letter by a machine. They plugged it into yeast and it worked. “I was super excited, really proud and also relieved,” Smolke says. “It was a bit of a Hail Mary.” The discovery enabled Smolke’s lab to stitch together a pathway of 23 different genes from plants, mammals, bacteria and yeast to produce the world’s first narcotic through synthetic biology (S. Galanie et al. Science 349, 1095–1100; 2015). It was a crowning achievement for a biological wunderkind who started her own lab at the California Institute of Technology in Pasadena at the age of just 28. The opioid-producing yeast cells contain the most complex synthetic-biology pathway developed so far, and mark a turning point for the field by showing how step-by-step engineering can turn microbes into drug factories. “This will significantly impact our future ability to produce many more chemicals through biotech­nology,” says Jens Nielsen, a synthetic biologist at the Chalmers University of Technology in Gothenburg, Sweden. Much of the news coverage of the work, however, stirred fears about how it could foster new ways to easily manufacture illegal drugs — and some scientists have argued for tighter regulation of the growing field. Smolke counters that existing regulations already restrict the production and distribution of narcotics; any lab that wishes to work with the yeast strain reported in her paper, for instance, must be licensed by the US Drug Enforcement Administration. So far, no one has requested the strain. In a bid to ground the debate in reality, Smolke, her husband — fellow Stanford synthetic biologist Drew Endy — and another colleague this year attempted to brew opioids using her lab’s strain and standard beer-making equipment (D. Endy et al. Preprint at bioRxiv http://doi.org/9t2; 2015). The set-up produced only a trace amount of reticuline and none of the downstream chemical, thebaine, that is used to synthesize commercial drugs such as oxycodone and oxymorphone — suggesting that it would be difficult for the average home-brewer to start making these pharmaceuticals. (The scientists’ positive fermentation control, an English ale, was “palatable”, the manuscript notes.) Smolke co-founded a company, Antheia, based in Palo Alto, to produce opiate drugs in yeast commercially, and specialists in the field suspect that more will follow. But some onlookers are circumspect. Plant biologist Ian Graham at the University of York, UK, says that it will be hard to beat poppies. “Where plants already do it very well, the arguments for taking a synthetic-biology route are much less convincing,” he says. For Smolke, the goal is not merely to copy plants, but to engineer opioids that are free of side effects such as dependency and addiction. Sitting in the office of a Palo Alto incubator space, wearing jeans and grey Converse sneakers to a meeting with the co-founders of Antheia, Smolke can appear casual — but the intensity that has propelled her to the pinnacle of her field is tangible. For her, the year’s accomplishments are just part of a quest to understand and improve on opioids, which are among the most complex natural chemicals . “It’s a very powerful approach to take inspiration from nature and go beyond it,” she says. A psychologist pledged to improve reproducibility in science. By Brendan Maher When Brian Nosek was a graduate student in experimental psychology, he started working on the implicit-association test, which reveals people’s unconscious prejudices with the push of a button. Tap right every time a male name appears on a screen, for example, and left for a female name. That’s easy — but add some stereotypically male or female roles into the mix and things get interesting. Even the most liberal minds will sometimes stall when asked to press the same button for the word ‘executive’ and for the name ‘Susan’. The tests are challenging, informative and kind of fun. So in 1998 Nosek convinced his mentors, who had developed the test, to put it online. It was a success: about a million people per year now take the test for research, corporate training and other reasons. “It really spread the word about what unconscious bias is,” says Betsy Levy Paluck, a social psychologist at Princeton University, New Jersey. For Nosek, a key demographic still needs to be educated about their biases: scientists. Nosek is convinced that researchers are unconsciously influenced by their hypotheses, that these biases can be seen in common practices that distort the interpretation of data such as p-value hacking, and that they are major drivers of the much-discussed crisis in research reproducibility. In 2013, Nosek took leave from his post at the University of Virginia in Charlottesville to co-found the Center for Open Science (COS), a non-profit company that builds tools to facilitate better research methodology. It hit several milestones this year, accumulating US$18 million in funding and a staff of 68. Nosek also co-authored a set of guidelines for transparency and openness that more than 500 journals have signed up to (B. A. Nosek et al. Science 348, 1422–1425; 2015). But the COS’s most visible output in 2015 was the Reproducibility Project, an ambitious attempt to re-test seminal findings in 100 psychology papers (Open Science Collaboration Science http://doi.org/68c; 2015). The decision to run the project “was quite brave of him”, says Dorothy Bishop, a neuropsychologist at the University of Oxford, UK, because poor results could tarnish the field’s reputation. In the end, 61 of the findings could not be replicated — but the outcome was mostly received well, something for which many psychologists credit Nosek’s careful diplomacy and can-do approach. Nosek is pushing researchers to adopt practices that will improve reproducibility, including preregistering studies, tracking the results in an open way and publishing them whether they are positive or negative. It will be a dramatic culture change, says Bishop, who has begun using systems developed by the COS for her own research. “Yes, it creates a lot more work. You have to document and check it very thoroughly. But it’s not a bad thing to be slowed down a bit.” A second reproducibility project that is focused on findings in cancer biology should begin releasing results next year, and Nosek says that negotiations are in the works for similar projects in ecology and computer science. No one operates completely free of bias, he says, and that includes him. “I try to have some humility and understanding that I am as prone to these behaviours as anyone else.” Gianotti will take charge at the European lab as its Large Hadron Collider clocks up record high-energy particle collisions— and as hopes of the next big discovery soar. If rumours that this observatory has detected gravitational waves prove true, one of the most elusive predictions of the general theory of relativity would be confirmed. By applying for approval to edit the genomes of human embryos, Niakan has placed herself at the front of the fast-moving, controversial CRISPR–Cas9 field. There is intense curiosity about what will emerge next from Hassabis’s efforts to combine neuroscience and machine learning at the Google-owned firm. Yang will be influential at this growing basic-research agency as China overhauls its funding systems and sets its next 5-year plan.


Axt J.R.,University of Virginia | Ebersole C.R.,University of Virginia | Nosek B.A.,University of Virginia | Nosek B.A.,Center for Open Science
Psychological Science | Year: 2014

The social world is stratified. Social hierarchies are known but often disavowed as anachronisms or unjust. Nonetheless, hierarchies may persist in social memory. In three studies (total N > 200,000), we found evidence of social hierarchies in implicit evaluation by race, religion, and age. Participants implicitly evaluated their own racial group most positively and the remaining racial groups in accordance with the following hierarchy: Whites > Asians > Blacks > Hispanics. Similarly, participants implicitly evaluated their own religion most positively and the remaining religions in accordance with the following hierarchy: Christianity > Judaism > Hinduism or Buddhism > Islam. In a final study, participants of all ages implicitly evaluated age groups following this rule: children > young adults > middle-age adults > older adults. These results suggest that the rules of social evaluation are pervasively embedded in culture and mind. © The Author(s) 2014.


Ebersole C.R.,University of Virginia | Axt J.R.,University of Virginia | Nosek B.A.,University of Virginia | Nosek B.A.,Center for Open Science
PLoS Biology | Year: 2016

Replication is vital for increasing precision and accuracy of scientific claims. However, when replications “succeed” or “fail,” they could have reputational consequences for the claim’s originators. Surveys of United States adults (N = 4,786), undergraduates (N = 428), and researchers (N = 313) showed that reputational assessments of scientists were based more on how they pursue knowledge and respond to replication evidence, not whether the initial results were true. When comparing one scientist that produced boring but certain results with another that produced exciting but uncertain results, opinion favored the former despite researchers’ belief in more rewards for the latter. Considering idealized views of scientific practices offers an opportunity to address incentives to reward both innovation and verification. © 2016 Ebersole et al.


News Article | October 6, 2016
Site: www.chromatographytechniques.com

With proper training and recently launched online software and web-portal, citizen scientists can follow scientific-based practices to improve environmental decision-making and even secure funding to help solve environmental problems, says a new study. Michigan State University researchers who led the research, featured in the current issue of Biological Conservation, showed that recent advances of online modeling tools and a web-based portal not only help bolster citizen science but the field of conservation biology as well. “The nature of citizen science is changing; citizens aren’t simply used solely for data collection,” said Steven Gray, MSU assistant professor of community sustainability and the study’s lead author. “They are designing the protocols, conducting the experiments, securing funding and implementing the plans. They may not have the credentials of scientists, but they have the capacity to engage in the same approaches.” For example, a community group in Virginia had concerns over the water quality of a stream that ran through agricultural land. They wanted to measure the benefits of fencing that kept cattle from wallowing in the stream. Using Mental Modeler www.mentalmodeler.org, special online software pioneered at MSU, the group was able to come up with a sensible solution to reduce water pollution. As part of the study, the Virginian community group also used a citizen science web portal, www.collaborativescience.org, developed with partners at Rutgers University and Colorado State University. This combination allowed the group to work with scientists and other stakeholders to define the issue as well as model and represent assumptions, evidence and existing information surrounding the problem. The end result saw landowners work with the local soil and water conservation district to secure funding for four miles of fencing and three wells, which act as buffers between the cattle and the stream. The team effort dramatically reduced water pollution, specifically E. coli contamination. Gray created Mental Modeler through funding from the United States Department of Agriculture and the National Science Foundation. The Collaborative Science project was designed to work with CitSci.org, which was developed at CSU and has helped nearly 340 projects and around 2,600 members. In an open, transparent environment, everyone involved in the project can discuss potential research or management options and, together, develop citizen scientific research and conservation plans. “With these online tools, we’re helping people tackle problems just as an interdisciplinary team of ecologists, biologists and economists would assess environmental issues,” said Gray, who’s with the College of Agriculture and Natural Resources. “We are helping to collectively bring everything in; our software is helping this happen.” There are myriad examples of how this software and this approach can be used. Wildlife biologists could team with hunters to help solve wolf- or deer-management issues; trout fishermen could work with ecologists, geologists and economists to address fracking activity and the impact on stream health; farmers could partner with entomologists to test vegetation proposals that attract beneficial bugs to a region; and many, many more. “The opportunities to use this software are truly endless,” Gray said. “This helps everyone in identifying the multitude of facets involved in an issue and to run ‘what-if’ scenarios to see how the system, whatever it may be, reacts to changes.” And in the case of the Virginia environmental group, allows everyone to contribute to a viable solution that benefits the environment. Researchers from Colorado State University, Rutgers University, Virginia Polytechnic University, Indiana University and the Center for Open Science contributed to this research. This research was funded by the National Science Foundation.

Loading Center for Open Science collaborators
Loading Center for Open Science collaborators